PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s ARKG Position: Q1 2026 in Review
PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 270 shares — an estimated $7.82K sold.
PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in ARKG in Q4 2022 and held it in 13 quarters. The position peaked at $15.6K in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 270 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $7.82K.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 13 quarters.
- PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s ARK Genomic Revolution ETF position peaked at $15.6K in Q4 2023.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q1 2026, filed 7 Aug 2026.